Government as the First Investor in Biopharmaceutical Innovation: Evidence From New Drug Approvals 2010–2019

Institute for New Economic Thinking Working Paper Series. 2020:1-72. doi: 10.36687/inetwp133

The discovery and development of new medicines classically involves a linear process of basic biomedical research to uncover potential targets for drug action, followed by applied, or translational, research to identify candidate products and establish their effectiveness and safety.

Library Collection(s)